Literature DB >> 26362398

Magnetic resonance-transcranial ultrasound fusion imaging: A novel tool for brain electrode location.

Uwe Walter1, Jan-Uwe Müller2, Johannes Rösche1, Michael Kirsch3, Annette Grossmann4, Reiner Benecke1, Matthias Wittstock1, Alexander Wolters1.   

Abstract

BACKGROUND: A combination of preoperative magnetic resonance imaging (MRI) with real-time transcranial ultrasound, known as fusion imaging, may improve postoperative control of deep brain stimulation (DBS) electrode location. Fusion imaging, however, employs a weak magnetic field for tracking the position of the ultrasound transducer and the patient's head. Here we assessed its feasibility, safety, and clinical relevance in patients with DBS.
METHODS: Eighteen imaging sessions were conducted in 15 patients (7 women; aged 52.4 ± 14.4 y) with DBS of subthalamic nucleus (n = 6), globus pallidus interna (n = 5), ventro-intermediate (n = 3), or anterior (n = 1) thalamic nucleus and clinically suspected lead displacement. Minimum distance between DBS generator and magnetic field transmitter was kept at 65 cm. The pre-implantation MRI dataset was loaded into the ultrasound system for the fusion imaging examination. The DBS lead position was rated using validated criteria. Generator DBS parameters and neurological state of patients were monitored.
RESULTS: Magnetic resonance-ultrasound fusion imaging and volume navigation were feasible in all cases and provided with real-time imaging capabilities of DBS lead and its location within the superimposed magnetic resonance images. Of 35 assessed lead locations, 30 were rated optimal, three suboptimal, and two displaced. In two cases, electrodes were re-implanted after confirming their inappropriate location on computed tomography (CT) scan. No influence of fusion imaging on clinical state of patients, or on DBS implantable pulse generator function, was found.
CONCLUSIONS: Magnetic resonance-ultrasound real-time fusion imaging of DBS electrodes is safe with distinct precautions and improves assessment of electrode location. It may lower the need for repeated CT or MRI scans in DBS patients.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; dystonia; magnetic field strength; transcranial sonography

Mesh:

Year:  2015        PMID: 26362398     DOI: 10.1002/mds.26425

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Selective Mapping of Deep Brain Stimulation Lead Currents Using Acoustoelectric Imaging.

Authors:  Chet Preston; Willard S Kasoff; Russell S Witte
Journal:  Ultrasound Med Biol       Date:  2018-08-14       Impact factor: 2.998

2.  Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine.

Authors:  Huaijun Wang; Stephen A Felt; Ismayil Guracar; Valentina Taviani; Jianhua Zhou; Rosa Maria Silveira Sigrist; Huiping Zhang; Joy Liau; José G Vilches-Moure; Lu Tian; Yamil Saenz; Thierry Bettinger; Brian A Hargreaves; Amelie M Lutz; Jürgen K Willmann
Journal:  Eur Radiol       Date:  2017-11-23       Impact factor: 5.315

3.  High resolution transcranial acoustoelectric imaging of current densities from a directional deep brain stimulator.

Authors:  Chet Preston; Alexander M Alvarez; Andres Barragan; Jennifer Becker; Willard S Kasoff; Russell S Witte
Journal:  J Neural Eng       Date:  2020-02-27       Impact factor: 5.379

4.  Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.

Authors:  Seyed-Ahmad Ahmadi; Kai Bötzel; Johannes Levin; Juliana Maiostre; Tassilo Klein; Wolfgang Wein; Verena Rozanski; Olaf Dietrich; Birgit Ertl-Wagner; Nassir Navab; Annika Plate
Journal:  Neuroimage Clin       Date:  2020-02-01       Impact factor: 4.881

5.  Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.

Authors:  Isabelle Kühn; Henning Maschke; Annette Großmann; Karlheinz Hauenstein; Marc-André Weber; Uwe K Zettl; Alexander Storch; Uwe Walter
Journal:  Neurol Sci       Date:  2021-11-04       Impact factor: 3.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.